Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 11Not yet recruiting 3Unknown 2Terminated 2Recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Gastroesophageal Reflux 1Gastritis 1Esophagitis 1Barrett Esophagus 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × Esomeprazole × Clear all
NCT05100446 2021-10-29

Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

Unidade Local de Saúde do Alto Ave, EPE

Phase EARLY_PHASE1 Unknown
100 enrolled
Gastrointestinal

Gastritis, Stomach Neoplasms

NCT00216788 2010-03-16

The Effect of Nexium on Transmucosal Esophageal Leak

Main Line Health

Phase 1 Unknown
35 enrolled
Gastrointestinal

Barrett Esophagus, Esophagitis, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡